Real-time amyloid aggregation monitoring with a photonic crystal-based approach

Sara Santi, Valeria Musi, Emiliano Descrovi, Vincent Paeder, Joab Di Francesco, Lubos Hvozdara, Peter Van Der Wal, Hilal A. Lashuel, Annalisa Pastore, Reinhard Neier, Hans Peter Herzig

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

We propose the application of a new label-free optical technique based on photonic nanostructures to real-time monitor the amyloid-beta 1-42 (Aβ(1-42)) fibrillization, including the early stages of the aggregation process, which are related to the onset of the Alzheimer's Disease (AD). The aggregation of Aβ peptides into amyloid fibrils has commonly been associated with neuronal death, which culminates in the clinical features of the incurable degenerative AD. Recent studies revealed that cell toxicity is determined by the formation of soluble oligomeric forms of Aβ peptides in the early stages of aggregation. At this phase, classical amyloid detection techniques lack in sensitivity. Upon a chemical passivation of the sensing surface by means of polyethylene glycol, the proposed approach allows an accurate, real-time monitoring of the refractive index variation of the solution, wherein Aβ(1-42) peptides are aggregating. This measurement is directly related to the aggregation state of the peptide throughout oligomerization and subsequent fibrillization. Our findings open new perspectives in the understanding of the dynamics of amyloid formation, and validate this approach as a new and powerful method to screen aggregation at early stages. Catching the wave: A Bloch surface wave (BSW) is generated at the interface between a dielectric multilayer structure and a solution containing the Aβ(1-42) peptide. The BSW is sensitive to the variation of the refractive index (Δn) of the solution. This variation is related to conformational changes of the Aβ(1-42) peptide during aggregation, that is, the transition from an initial soluble form to a non-soluble fibrillar state (see figure).

Original languageEnglish
Pages (from-to)3476-3482
Number of pages7
JournalChemPhysChem
Volume14
Issue number15
DOIs
Publication statusPublished - 21 Oct 2013
Externally publishedYes

Fingerprint

Optics and Photonics
Photonic crystals
Amyloid
peptides
Agglomeration
photonics
Peptides
Monitoring
crystals
Refractometry
Surface waves
surface waves
Refractive index
Alzheimer Disease
refractivity
Oligomerization
Nanostructures
Passivation
death
toxicity

Keywords

  • aggregation
  • Alzheimer's disease
  • amyloid beta-peptides
  • biosensing
  • photonic crystals

ASJC Scopus subject areas

  • Physical and Theoretical Chemistry
  • Atomic and Molecular Physics, and Optics

Cite this

Santi, S., Musi, V., Descrovi, E., Paeder, V., Di Francesco, J., Hvozdara, L., ... Herzig, H. P. (2013). Real-time amyloid aggregation monitoring with a photonic crystal-based approach. ChemPhysChem, 14(15), 3476-3482. https://doi.org/10.1002/cphc.201300633

Real-time amyloid aggregation monitoring with a photonic crystal-based approach. / Santi, Sara; Musi, Valeria; Descrovi, Emiliano; Paeder, Vincent; Di Francesco, Joab; Hvozdara, Lubos; Van Der Wal, Peter; Lashuel, Hilal A.; Pastore, Annalisa; Neier, Reinhard; Herzig, Hans Peter.

In: ChemPhysChem, Vol. 14, No. 15, 21.10.2013, p. 3476-3482.

Research output: Contribution to journalArticle

Santi, S, Musi, V, Descrovi, E, Paeder, V, Di Francesco, J, Hvozdara, L, Van Der Wal, P, Lashuel, HA, Pastore, A, Neier, R & Herzig, HP 2013, 'Real-time amyloid aggregation monitoring with a photonic crystal-based approach', ChemPhysChem, vol. 14, no. 15, pp. 3476-3482. https://doi.org/10.1002/cphc.201300633
Santi S, Musi V, Descrovi E, Paeder V, Di Francesco J, Hvozdara L et al. Real-time amyloid aggregation monitoring with a photonic crystal-based approach. ChemPhysChem. 2013 Oct 21;14(15):3476-3482. https://doi.org/10.1002/cphc.201300633
Santi, Sara ; Musi, Valeria ; Descrovi, Emiliano ; Paeder, Vincent ; Di Francesco, Joab ; Hvozdara, Lubos ; Van Der Wal, Peter ; Lashuel, Hilal A. ; Pastore, Annalisa ; Neier, Reinhard ; Herzig, Hans Peter. / Real-time amyloid aggregation monitoring with a photonic crystal-based approach. In: ChemPhysChem. 2013 ; Vol. 14, No. 15. pp. 3476-3482.
@article{77fe316cb88e4fe98f32ccaf85418e6a,
title = "Real-time amyloid aggregation monitoring with a photonic crystal-based approach",
abstract = "We propose the application of a new label-free optical technique based on photonic nanostructures to real-time monitor the amyloid-beta 1-42 (Aβ(1-42)) fibrillization, including the early stages of the aggregation process, which are related to the onset of the Alzheimer's Disease (AD). The aggregation of Aβ peptides into amyloid fibrils has commonly been associated with neuronal death, which culminates in the clinical features of the incurable degenerative AD. Recent studies revealed that cell toxicity is determined by the formation of soluble oligomeric forms of Aβ peptides in the early stages of aggregation. At this phase, classical amyloid detection techniques lack in sensitivity. Upon a chemical passivation of the sensing surface by means of polyethylene glycol, the proposed approach allows an accurate, real-time monitoring of the refractive index variation of the solution, wherein Aβ(1-42) peptides are aggregating. This measurement is directly related to the aggregation state of the peptide throughout oligomerization and subsequent fibrillization. Our findings open new perspectives in the understanding of the dynamics of amyloid formation, and validate this approach as a new and powerful method to screen aggregation at early stages. Catching the wave: A Bloch surface wave (BSW) is generated at the interface between a dielectric multilayer structure and a solution containing the Aβ(1-42) peptide. The BSW is sensitive to the variation of the refractive index (Δn) of the solution. This variation is related to conformational changes of the Aβ(1-42) peptide during aggregation, that is, the transition from an initial soluble form to a non-soluble fibrillar state (see figure).",
keywords = "aggregation, Alzheimer's disease, amyloid beta-peptides, biosensing, photonic crystals",
author = "Sara Santi and Valeria Musi and Emiliano Descrovi and Vincent Paeder and {Di Francesco}, Joab and Lubos Hvozdara and {Van Der Wal}, Peter and Lashuel, {Hilal A.} and Annalisa Pastore and Reinhard Neier and Herzig, {Hans Peter}",
year = "2013",
month = "10",
day = "21",
doi = "10.1002/cphc.201300633",
language = "English",
volume = "14",
pages = "3476--3482",
journal = "ChemPhysChem",
issn = "1439-4235",
publisher = "Wiley-VCH Verlag",
number = "15",

}

TY - JOUR

T1 - Real-time amyloid aggregation monitoring with a photonic crystal-based approach

AU - Santi, Sara

AU - Musi, Valeria

AU - Descrovi, Emiliano

AU - Paeder, Vincent

AU - Di Francesco, Joab

AU - Hvozdara, Lubos

AU - Van Der Wal, Peter

AU - Lashuel, Hilal A.

AU - Pastore, Annalisa

AU - Neier, Reinhard

AU - Herzig, Hans Peter

PY - 2013/10/21

Y1 - 2013/10/21

N2 - We propose the application of a new label-free optical technique based on photonic nanostructures to real-time monitor the amyloid-beta 1-42 (Aβ(1-42)) fibrillization, including the early stages of the aggregation process, which are related to the onset of the Alzheimer's Disease (AD). The aggregation of Aβ peptides into amyloid fibrils has commonly been associated with neuronal death, which culminates in the clinical features of the incurable degenerative AD. Recent studies revealed that cell toxicity is determined by the formation of soluble oligomeric forms of Aβ peptides in the early stages of aggregation. At this phase, classical amyloid detection techniques lack in sensitivity. Upon a chemical passivation of the sensing surface by means of polyethylene glycol, the proposed approach allows an accurate, real-time monitoring of the refractive index variation of the solution, wherein Aβ(1-42) peptides are aggregating. This measurement is directly related to the aggregation state of the peptide throughout oligomerization and subsequent fibrillization. Our findings open new perspectives in the understanding of the dynamics of amyloid formation, and validate this approach as a new and powerful method to screen aggregation at early stages. Catching the wave: A Bloch surface wave (BSW) is generated at the interface between a dielectric multilayer structure and a solution containing the Aβ(1-42) peptide. The BSW is sensitive to the variation of the refractive index (Δn) of the solution. This variation is related to conformational changes of the Aβ(1-42) peptide during aggregation, that is, the transition from an initial soluble form to a non-soluble fibrillar state (see figure).

AB - We propose the application of a new label-free optical technique based on photonic nanostructures to real-time monitor the amyloid-beta 1-42 (Aβ(1-42)) fibrillization, including the early stages of the aggregation process, which are related to the onset of the Alzheimer's Disease (AD). The aggregation of Aβ peptides into amyloid fibrils has commonly been associated with neuronal death, which culminates in the clinical features of the incurable degenerative AD. Recent studies revealed that cell toxicity is determined by the formation of soluble oligomeric forms of Aβ peptides in the early stages of aggregation. At this phase, classical amyloid detection techniques lack in sensitivity. Upon a chemical passivation of the sensing surface by means of polyethylene glycol, the proposed approach allows an accurate, real-time monitoring of the refractive index variation of the solution, wherein Aβ(1-42) peptides are aggregating. This measurement is directly related to the aggregation state of the peptide throughout oligomerization and subsequent fibrillization. Our findings open new perspectives in the understanding of the dynamics of amyloid formation, and validate this approach as a new and powerful method to screen aggregation at early stages. Catching the wave: A Bloch surface wave (BSW) is generated at the interface between a dielectric multilayer structure and a solution containing the Aβ(1-42) peptide. The BSW is sensitive to the variation of the refractive index (Δn) of the solution. This variation is related to conformational changes of the Aβ(1-42) peptide during aggregation, that is, the transition from an initial soluble form to a non-soluble fibrillar state (see figure).

KW - aggregation

KW - Alzheimer's disease

KW - amyloid beta-peptides

KW - biosensing

KW - photonic crystals

UR - http://www.scopus.com/inward/record.url?scp=84885953068&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885953068&partnerID=8YFLogxK

U2 - 10.1002/cphc.201300633

DO - 10.1002/cphc.201300633

M3 - Article

VL - 14

SP - 3476

EP - 3482

JO - ChemPhysChem

JF - ChemPhysChem

SN - 1439-4235

IS - 15

ER -